Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorin Toader

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Organic Chemistry|October 18, 1996
General and Efficient Insertions of Carbons Carrying Aryl and Heteroaryl Groups: Synthesis of alpha-Aryl- and alpha-Heteroaryl-Substituted KetonesAlan R. Katritzky, Dorin Toader, Linghong Xie
Trends in Pharmacological Sciences|April 17, 2012
Structural approaches to obtain kinase selectivityRichard A Norman, Dorin Toader, Andrew D Ferguson
The Journal of Organic Chemistry|October 25, 2001
A Four-Carbon Unit Reagent for the Regiospecific Synthesis of 2-Alkyl-Substituted 1,3-ButadienesAlan R. Katritzky, Larisa Serdyuk, Dorin Toader, et al.
Blood|June 1, 2012
Essential role of TAK1 in regulating mantle cell lymphoma survivalDaniela Buglio, Sangeetha Palakurthi, Kate Byth, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2025
PBPK Modeling to Predict Clinical Drug-Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F-HydroxypropylamideNiyanta Kumar, Vaishali Dixit, Howard Burt, et al.
Journal of Medicinal Chemistry|November 5, 2016
Structure-Cytotoxicity Relationships of Analogues of N<sup>14</sup>-Desacetoxytubulysin HDorin Toader, Fengjiang Wang, Lakshmaiah Gingipalli, et al.
ACS Chemical Biology|January 1, 2013
Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-OxozeaenolJiaquan Wu, Francoise Powell, Nicholas A Larsen, et al.
ACS Medicinal Chemistry Letters|November 25, 2016
Straightforward Glycoengineering Approach to Site-Specific Antibody-Pyrrolobenzodiazepine ConjugatesPamela Thompson, Ebele Ezeadi, Ian Hutchinson, et al.
Nature Communications|July 11, 2024
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responsesNaniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitorsVibha Oza, Susan Ashwell, Patrick Brassil, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Organic Chemistry|October 18, 1996
General and Efficient Insertions of Carbons Carrying Aryl and Heteroaryl Groups: Synthesis of alpha-Aryl- and alpha-Heteroaryl-Substituted KetonesAlan R. Katritzky, Dorin Toader, Linghong Xie
Trends in Pharmacological Sciences|April 17, 2012
Structural approaches to obtain kinase selectivityRichard A Norman, Dorin Toader, Andrew D Ferguson
The Journal of Organic Chemistry|October 25, 2001
A Four-Carbon Unit Reagent for the Regiospecific Synthesis of 2-Alkyl-Substituted 1,3-ButadienesAlan R. Katritzky, Larisa Serdyuk, Dorin Toader, et al.
Blood|June 1, 2012
Essential role of TAK1 in regulating mantle cell lymphoma survivalDaniela Buglio, Sangeetha Palakurthi, Kate Byth, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 31, 2025
PBPK Modeling to Predict Clinical Drug-Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F-HydroxypropylamideNiyanta Kumar, Vaishali Dixit, Howard Burt, et al.
Journal of Medicinal Chemistry|November 5, 2016
Structure-Cytotoxicity Relationships of Analogues of N<sup>14</sup>-Desacetoxytubulysin HDorin Toader, Fengjiang Wang, Lakshmaiah Gingipalli, et al.
ACS Chemical Biology|January 1, 2013
Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-OxozeaenolJiaquan Wu, Francoise Powell, Nicholas A Larsen, et al.
ACS Medicinal Chemistry Letters|November 25, 2016
Straightforward Glycoengineering Approach to Site-Specific Antibody-Pyrrolobenzodiazepine ConjugatesPamela Thompson, Ebele Ezeadi, Ian Hutchinson, et al.
Nature Communications|July 11, 2024
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responsesNaniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitorsVibha Oza, Susan Ashwell, Patrick Brassil, et al.
Pageof 3